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Abstract
Background: Carbon tetrachloride (CCl4) is a well-known hepatotoxin and exposure to this
chemical is known to induce oxidative stress and causes liver injury by the formation of free
radicals. Acute and chronic renal damage are also very common pathophysiologic disturbances
caused by CCl4. The present study has been conducted to evaluate the protective role of the
aqueous extract of the bark of Termnalia arjuna (TA), an important Indian medicinal plant widely
used in the preparation of ayurvedic formulations, on CCl4 induced oxidative stress and resultant
dysfunction in the livers and kidneys of mice.
Methods: Animals were pretreated with the aqueous extract of TA (50 mg/kg body weight) for
one week and then challenged with CCl4 (1 ml/kg body weight) in liquid paraffin (1:1, v/v) for 2 days.
Serum marker enzymes, namely, glutamate pyruvate transaminase (GPT) and alkaline phosphatase
(ALP) were estimated in the sera of all study groups. Antioxidant status in both the liver and kidney
tissues were estimated by determining the activities of the antioxidative enzymes, superoxide
dismutase (SOD), catalase (CAT) and glutathione-S-transferase (GST); as well as by determining
the levels of thiobarbutaric acid reactive substances (TBARS) and reduced glutathione (GSH). In
addition, free radical scavenging activity of the extract was determined from its DPPH radical
quenching ability.
Results: Results showed that CCl4 caused a marked rise in serum levels of GPT and ALP. TBARS
level was also increased significantly whereas GSH, SOD, CAT and GST levels were decreased in
the liver and kidney tissue homogenates of CCl4 treated mice. Aqueous extract of TA successfully
prevented the alterations of these effects in the experimental animals. Data also showed that the
extract possessed strong free radical scavenging activity comparable to that of vitamin C.
Conclusion: Our study demonstrated that the aqueous extract of the bark of TA could protect
the liver and kidney tissues against CCl4-induced oxidative stress probably by increasing
antioxidative defense activities.
Background
Exposure to various organic compounds including a
number of environmental pollutants and drugs can cause
cellular damages through metabolic activation of those
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compounds to highly reactive substances such as reactive
oxygen species (ROS). Free radical induced lipid peroxida-
tion is believed to be one of the major causes of cell mem-
brane damage leading to a number of pathological
situations [1-3]. Reports from our laboratory and other
investigators have established that the industrial solvent,
carbon tetrachloride (CCl4) is a potent environmental
hepatotoxin [4-7]. A number of recent reports clearly
demonstrated that in addition to hepatic problems, CCl4
also causes disorders in kidneys, lungs, testis and brain as
well as in blood by generating free radicals [8-11]. Reports
from Perez et al, Ogeturk et al and Churchill et al sug-
gested that exposure to this solvent causes acute and
chronic renal injuries [12-14]. In addition, reports on var-
ious documented case studies established that CCl4 pro-
duces renal diseases in humans [15,16]. Extensive
evidence demonstrated that .CCl3 and .Cl are formed as a
result of the metabolic activation of CCl4, which in turn,
initiate lipid peroxidation process. A known potent anti-
oxidant, vitamin E, could protect CCl4 induced liver injury
indicating that oxidative stress is responsible for CCl4
induced hepatic disorder in this particular model [17,18].
Studies also showed that various herbal extracts could
protect organs against CCl4 induced oxidative stress by
altering the levels of increased lipid peroxidation, and
enhancing the decreased activities of antioxidant
enzymes, like superoxide dismutase (SOD), catalase
(CAT) and glutathione-S-transferase (GST) as well as
enhanced the decreased level of the hepatic reduced glu-
tathione (GSH) [19,20]. Knowledge on the protective
mechanisms against toxin and drug induced organ-toxici-
ties leads scientists to look for biologically active relevant
compounds from herbal plants, which can possess intrin-
sic antioxidant activity and protect those organs from
unwanted oxidative stress. In the modern medicine,
plants occupy a significant birth as raw materials for some
important drug preparations [21-23]. India is well known
for a plethora of medicinal plants. The traditional Indian
medicinal plants act as antiradicals and DNA cleavage
protectors [24]. These plants have also been considered to
protect health, longevity, intelligence, immunosurveil-
lance and body resistance against different infections and
diseases. Tephrosia purpurea [25], Silybum marianum [26],
Picrorhiza kurroa [27], Cajanus indicus [28,29], Phyllanthus
niruri  [30-32], etc. posses hepatoprotective property
against different toxins and drugs induced hepatic disor-
ders. Terminalia arjuna (TA) is also an important medici-
nal plant widely used in the preparation of ayurvedic
formulations for over three centuries primarily as a car-
diac tonic in India [33]. Clinical evaluation of this plant
indicates that it can be of benefit in the treatment of coro-
nary artery diseases, heart failure and possibly hypercho-
lesterolemia [34-36]. It has also been found to be
antibacterial and antimutagenic [37-39]. However, most
of the beneficial works on this plant have been carried out
on the alcoholic extract of its bark and very little is known
about its role on toxin-induced either hepatic or renal dis-
orders. In this particular study, protective role of aqueous
extract of the bark of TA was evaluated against CCl4-
induced toxicity in the liver and kidney. Firstly, the radical
scavenging activity of the extract was determined from its
2,2-diphenyl-1-picryl hydrazyl (DPPH) radical quenching
ability and the data were compared to those obtained
from a known free radical scavenger, vitamin C. Secondly,
the dose- and time-dependent effects of the extract against
CCl4-induced toxicity were evaluated by measuring the
levels of the serum marker enzymes, glutamate pyruvate
transaminase (GPT) followed by determining its effect on
another serum marker enzyme, alkaline phosphatase
(ALP) using optimum dose and time. Finally, hepatic and
renal oxidant-antioxidant status was evaluated by measur-
ing the levels of a) antioxidant enzymes SOD, CAT and
GST; b) ROS scavenger GSH and c) extent of lipid peroxi-
dation in both the livers as well as the kidneys in mice. In
addition, study on the effect of a known antioxidant, vita-
min E, was also included against CCl4 induced hepatic
and renal oxidative stress.
Methods
Plant
Terminalia arjuna (TA), belonging to the family Combreta-
ceae, has a long history of medicinal uses in India. It is a
shade and ornamental tree. The bark of the tree is useful
as an anti-ischemic and cardioprotective agent in hyper-
tension and in ischemic heart disease. The bark was col-
lected from local markets.
Animals
Swiss albino mice (male, body weight 20 ± 2 g) were accli-
matized under laboratory condition for a fortnight before
starting experiments. They were provided with standard
diet and water ad libitum. The animals were divided into
four groups, each group having six mice.
Chemicals
Bradford reagent, bovine serum albumin (BSA), DPPH,
and protein estimation kit were purchased from Sigma-
Aldrich Chemical Company, (St. Louis, MO) USA. CCl4,
1-chloro-2,4-dinitrobenzene (CDNB), 5,5'-dithiobis(2-
nitrobenzoic acid) [DTNB, (Ellman's reagent)], disodium
hydrogen phosphate (Na2HPO4), ethylene diamine
tetraacetic acid (EDTA), glacial acetic acid, hydrogen per-
oxide (H2O2), nicotinamide adenine dinucleotide
reduced (NADH), nitro blue tetrazolium (NBT), phena-
zine methosulphate (PMT), potassium dihydrogen phos-
phate (KH2PO4), reduced glutathione (GSH), sodium
dihydrogen phosphate (NaH2PO4), sodium pyrophos-
phate, trichloro acetic acid (TCA), thiobarbituric acid
(TBA), vitamin C, vitamin E were bought from Sisco
research laboratory, India.BMC Complementary and Alternative Medicine 2006, 6:33 http://www.biomedcentral.com/1472-6882/6/33
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Preparation of aqueous extract of TA
The bark of TA was cut into pieces and was homogenized
in 50 mM sodium phosphate buffer; pH 7.2, at 4°C and
the homogenate was centrifuged at 12,000 g for 30 min-
utes to get rid of unwanted debris. The supernatant was
dialyzed against ice-cold water and centrifuged again
under the same condition. The supernatant was collected
and lyophilized. The freeze-dried material was weighed,
dissolved in the same phosphate buffer and used for this
study.
Determination of radical scavenger activity in cell-free 
system
Quenching of DPPH radical
The radical scavenger activity of the aqueous TA extract
was measured spectrophotometrically using the DPPH
radical [40]. Aqueous TA extract at various concentrations
were added to DPPH in methanol (125 μM, 2 ml) solu-
tion. The final volume was adjusted to 4 ml with water.
The solution was shaken and incubated at 37°C for 30
minutes in the dark. The decrease in absorbance of DPPH
was measured at 517 nm. Percent inhibition was calcu-
lated by comparing the absorbance values of the control
and the extract. A parallel experiment was carried out
under the same conditions in which TA extract was
replaced by vitamin C and used as a positive control.
Determination of dose-dependent effect of the extract
To determine the dose of the TA extract necessary for the
maximum hepatic and renal protection, six different
groups of mice were separately treated with six different
doses of the extract – 1 mg, 5 mg, 10 mg, 25 mg, 50 mg
and 100 mg/kg body weight for 7 days prior to CCl4 treat-
ment (in liquid paraffin 1:1, v/v) for 2 days at a dose of 1
ml/kg body weight. Twenty-four hours after the final dose
of CCl4 administration, all mice were sacrificed. The GPT
levels were measured from the blood sera of all the exper-
imental animals.
Determination of time-dependent effect of the extract
To determine the time needed for the TA extract to exhibit
maximum hepatic and renal protection, six different
groups of mice were separately treated with the extract at
a dose of 50 mg/kg body weight for 1, 3, 5, 7 and 10 days
prior to CCl4 (1 ml/kg body weight) intoxication. Twenty-
four hours after the final dose of CCl4 administration, all
experimental mice were sacrificed, blood samples were
collected and the GPT levels were measured.
Pre-treatment with the aqueous extract of TA
The pretreatment group was divided into three sub-groups
each consisted of six mice. The first group served as nor-
mal control. The second group received CCl4 orally (1 ml/
kg body weight) for 2 days and treated as toxin control.
The third group received the aqueous TA extract for 7 days
(50 mg/kg body weight) orally followed by CCl4 treat-
ment at a dose of 1 ml/kg body weight for 2 days. Mice
were sacrificed after 24 hours of the final dose of CCl4
administration and blood, livers and kidneys were col-
lected. For the positive control vitamin E (200 mg/kg
body weight) was administered orally to a group of 6 mice
for 7 days followed by CCl4 administration as described
earlier.
Preparation of liver and kidney homogenates
About 200 mg of liver and kidney tissue were homoge-
nized separately in 10 volume of 100 mM KH2PO4 buffer
containing 1 mM EDTA, pH 7.4 and centrifuged at 12,000
g for 30 minutes at 4°C. The supernatant was collected
and used for following experiments as described below.
Protein concentration of the supernatant was measured
according to the method of Bradford [41] using crystalline
BSA as standard.
Assessment of serum specific markers enzymes
Blood samples collected from puncturing mice hearts
were kept overnight for clotting and then centrifuged at
3,000 g for 10 minutes. GPT and ALP levels in all the sam-
ple sera were estimated by the methods of Rietman and
Frankel [42] and Kind and King [43] respectively.
Assay of antioxidant enzymes in the liver and kidney 
homogenates
SOD assay
The activity of SOD was measured following the method
of Nishikimi [44] and then modified by Kakkar [45].
About 5 μg total protein from each of the liver and kidney
homogenates were mixed with sodium pyrophosphate
buffer, PMT and NBT. The reaction was started by the
addition of NADH. The reaction mixture was incubated at
30°C for 90 seconds and stopped by the addition of 1 ml
of glacial acetic acid. The absorbance of the chromogen
formed was measured at 560 nm. One unit of SOD activ-
ity is defined as the enzyme concentration required for the
inhibition of chromogen production by 50% in one
minute under the assay conditions.
CAT assay
The enzyme CAT catalyzes the conversion of H2O2 into
water. The CAT activity was measured by the method of
Bonaventura [46]. About 5 μg protein from the liver and
kidney homogenates were mixed with 2.1 ml of 7.5 mM
H2O2 and the reaction was allowed to continue for 10
minutes at 25°C. The disappearance of peroxide was con-
tinuously recorded from the absorbance at 240 nm for the
specified period of time. One unit of CAT activity is
defined as the amount of enzyme necessary for reducing1
μmol of H2O2 per minute.BMC Complementary and Alternative Medicine 2006, 6:33 http://www.biomedcentral.com/1472-6882/6/33
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GST assay
GST catalyzes the conjugation reaction with glutathione
in the first step of mercapturic acid synthesis. GST activity
was measured by the method of Habig and Jakoby [47].
The reaction mixture contained suitable amount of the
enzyme (25 μg of protein in homogenates), KH2PO4
buffer, EDTA, CDNB and GSH. The reaction was carried
out at 37°C and monitored spectrophotometrically by the
increase in absorbance of the conjugate of GSH and
CDNB at 340 nm. A blank was run in absence of the
enzyme. One unit of GST activity is 1 μmol product for-
mation per minute.
Assay of non-enzymatic antioxidant in the liver and kidney 
homogenates
GSH assay
GSH level was measured by the method of Ellman [48].
The homogenate (720 μl) was double diluted and 5%
TCA was added to it to precipitate the protein content of
the homogenate. After centrifugation (10,000 g for 5 min-
utes) the supernatant was taken, DTNB solution (Ellman's
reagent) was added to it and the absorbance was meas-
ured at 412 nm. A standard graph was drawn using differ-
ent concentrations of a standard GSH solution (1 mg/ml).
With the help of the standard graph, GSH contents in the
liver and kidney homogenates of the experimental ani-
mals were calculated.
Estimation of lipid peroxidation products
Degree of lipid peroxidation in the liver and kidney tissue
homogenates of all the experimental animals was deter-
mined in terms of thiobarbituric acid reactive substances
(TBARS) formation [49]. The sample containing1 mg pro-
tein was mixed with 1 ml TCA (20%), 2 ml TBA (0.67%)
and heated for 1 hour at 100°C. After cooling, the precip-
itate was removed by centrifugation. The absorbance of
the sample was measured at 535 nm using a blank con-
taining all the reagents except the tissue homogenate. As
99% of the TBARS is malondialdehyde (MDA), TBARS
concentrations of the samples were calculated using the
extinction co-efficient of MDA, which is 1.56 × 105 M-1cm-
1.
Statistical analysis
All the values are represented as mean ± S.D. (n = 6). Data
on biochemical investigations were analyzed using analy-
sis of variance (ANOVA) and the group means were com-
pared by Duncan's Multiple Range Test (DMRT). A
probability of p < 0.05 was considered as significant.
Results
Effect of the aqueous TA extract on radical scavenger 
activity in cell-free system
Figure 1 shows the radical scavenging effect of the aque-
ous extract of the bark of TA. From the plot, it is evident
that with the increase in concentration of the aqueous TA
extract the inhibition of DPPH radical increases. Another
known free radical scavenger, vitamin C was also used in
the study. The figure also shows that the extract has com-
parable radical scavenging activity like vitamin C.
Dose-dependent preventive activity of the aqueous TA 
extract
Figure 2 shows the dose dependent preventive effect of the
extract against CCl4 intoxication. To determine at which
dose the extract exerts its maximum protective activity,
different doses were administered to six different groups
of mice. The extract was administered (1, 5, 10, 25, 50,
and 100 mg/kg body weight) for 7 days before CCl4 (1 ml/
kg body weight) intoxication. The preventive effect was
found to be the most when the extract was administered
at a dose of 50 mg/kg body weight prior to toxin adminis-
tration. The GPT values in figure 2 confirm the results.
Time-dependent preventive activity of the aqueous TA 
extract
Figure 3 shows the time-dependent preventive role of the
extract against CCl4 intoxication. The extract was adminis-
tered at a dose of 50 mg/kg body weight for 1, 3, 5, 7 and
10 days prior to CCl4 (1 ml/kg body weight) intoxication.
Administration of the extract prior to CCl4 intoxication
significantly prevented the disorder caused by the toxin as
evident from the lower levels of marker enzyme, GPT in
the blood serum. The maximum preventive effect was
DPPH radical scavenging activity of aqueous TA extract in  cell-free system Figure 1
DPPH radical scavenging activity of aqueous TA extract in 
cell-free system. The curve is obtained by plotting various 
concentrations of the extract (μg/ml) against percent inhibi-
tion of DPPH radical. Vitamin C (VitC) has been used as a 
known DPPH radical scavenger.
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observed when the extract was given for 7 days before
toxin administration.
Effect of the aqueous TA extract on ALP level
The ALP levels in all the experimental mice are shown in
figure 4. In CCl4 treated group, elevation of ALP level was
observed compared to the normal control group, whereas
ALP level decreased in the group of mice pretreated with
the aqueous extract for 7 days followed by CCl4 adminis-
tration of 2 days. Pretreatment with vitamin E also
reduced the elevated level of ALP.
Effect of the aqueous TA extract on SOD activity
The activities of SOD in the tissue homogenates of all
experimental mice are shown in figure 5. In the liver
homogenate CCl4 treatment caused reduction of the SOD
activity compared to the normal controls. Enhancement
of SOD activity was observed in case of 7 days treatment
of aqueous extract prior to the CCl4 administration. In the
kidney tissue homogenate the SOD activity in the CCl4
treated mice was reduced compared to the normal. Mice
receiving the aqueous extract prior to CCl4 showed an
increase in SOD value compared to the CCl4 treated mice.
Similar results were obtained with the antioxidant vita-
min E.
Effect of aqueous TA extract on ALP activity in blood serum  and against CCl4 intoxication (1 ml/kg body weight) Figure 4
Effect of aqueous TA extract on ALP activity in blood serum 
and against CCl4 intoxication (1 ml/kg body weight). Cont: 
ALP level in normal mice, CCl4: ALP level in CCl4 treated 
mice, TA+CCl4: ALP level in which extract was given at a 
dose 50 mg/kg body weight prior to CCl4 administration, 
VitE+CCl4: ALP level in which vitamin E was given at a dose 
of 200 mg/kg body weight prior to CCl4 administration. Each 
column represents mean ± SD, n = 6; (P* < 0.01, P** < 
0.001).
0
20
40
60
** **
*
A
L
P
 
(
K
A
 
U
n
i
t
s
/
m
l
 
s
e
r
u
m
)
Cont
CCl
4
TA+CCl
4
VitE+CCl
4
Time-dependent effect of aqueous TA extract on GPT level  against CCl4 induced toxicity Figure 3
Time-dependent effect of aqueous TA extract on GPT level 
against CCl4 induced toxicity. Cont: GPT level in normal 
mice, CCl4: GPT level in CCl4 treated mice, TA-1D+CCl4, 
TA-3D+CCl4,TA-5D+CCl4, TA-7D+CCl4 and TA-
10D+CCl4: GPT levels in extract treated mice applied for 1, 
3, 5, 7 and 10 days respectively at a dose of 50 mg/kg body 
weight before CCl4 (1 ml/kg body weight) administration. 
Each column represents mean ± SD, n = 6; (P* < 0.01, P** < 
0.001).
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Dose-dependent effect of aqueous TA extract on GPT level  against CCl4 induced toxicity Figure 2
Dose-dependent effect of aqueous TA extract on GPT level 
against CCl4 induced toxicity. Cont: GPT level in normal 
mice, CCl4: GPT level in CCl4 treated mice, TA-1+CCl4, TA-
5+CCl4, TA-10+CCl4, TA-25+CCl4, TA-50+CCl4 and TA-
100+CCl4: GPT levels in extract treated mice applied for 7 
days at a dose of 1, 5, 10, 25, 50 and 100 mg/kg body weight 
respectively before CCl4 administration (1 ml/kg body 
weight). Each column represents mean ± SD, n = 6; (P* < 
0.01, P** < 0.001).
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Effect of the aqueous TA extract on CAT activity
CAT activities in the liver and kidney homogenates of
mice for all experimental groups are shown in the figure
6. The CAT activity in the liver tissue homogenates of CCl4
treated mice was considerably lower than that of normal
control mice. In the pretreated group, which got the aque-
ous extract for 7 days prior to CCl4, CAT activity was sig-
nificantly higher compared to the CCl4 treated group. The
CAT activity in the kidney homogenates of CCl4 treated
mice was also lower than the normal control group. The
aqueous extract pretreated group showed increased CAT
activity, compared to the CCl4 treated group and it was
almost close to normal group. Vitamin E treatment prior
to CCl4 intoxication prevented the change in CAT activity
in either the liver and or the kidney homogenates.
Effect of the aqueous TA extract on GST activity
GST activity as measured from the liver and kidney tissue
homogenates of all the experimental mice have been
shown in figure 7. In the liver homogenates decreased
GST activity was observed in CCl4 treated mice compared
to the normal control group. Pretreatment with the aque-
ous extract for 7 days prior to CCl4 intoxication enhanced
that activity significantly. In the kidney homogenates GST
activity of CCl4 treated group was lower compared to that
in the normal group, while the GST activity was found to
be increased in the kidney homogenate of mice treated
with aqueous extract for 7 days prior to CCl4 treatment.
GST activity in vitamin E pretreated group was close to the
normal level.
Effect of the aqueous TA extract on GSH level
Effects of the aqueous extract on GSH level for all experi-
mental groups are shown in figure 8. CCl4  treatment
caused significant decrease of GSH level in liver tissue
homogenates compared to the normal group. Pretreat-
ment of aqueous extract for 7 days followed by 2 days
CCl4 treatment enhanced the level of GSH compared to
CCl4 treated group. Like liver, the GSH level in CCl4
treated group was also lower than the normal. Treatment
of the aqueous extract prior to the CCl4treatment
increased the GSH level. Similar results were obtained
with vitamin E.
Effect of aqueous TA extract on the CAT levels in CCl4  induced hepatic and renal damages in mice Figure 6
Effect of aqueous TA extract on the CAT levels in CCl4 
induced hepatic and renal damages in mice. Aqueous extract 
of TA was administered orally 7 days prior to CCl4 treat-
ment (1 ml/kg body weight). For experimental detail, see the 
materials and methods. Left panel shows the effects of the 
extract on liver and right panel shows that on the kidney 
against CCl4 induced CAT levels. Cont: CAT level in normal 
mice, CCl4: CAT level in only CCl4 treated mice, TA+CCl4: 
CAT level in which extract was given at a dose 50 mg/kg 
body weight prior to CCl4 administration, VitE+CCl4: CAT 
level in which vitamin E was given at a dose of 200 mg/kg 
body weight prior to CCl4 administration. Each column rep-
resents mean ± SD, n = 6; (P* < 0.01, P** < 0.001).
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Effect of aqueous TA extract on the SOD levels against CCl4  induced hepatic and renal damages in mice Figure 5
Effect of aqueous TA extract on the SOD levels against CCl4 
induced hepatic and renal damages in mice. Aqueous extract 
of TA was administered orally 7 days prior to CCl4 treat-
ment (1 ml/kg body weight). For experimental detail, see the 
materials and methods. Left panel shows the effects of the 
extract on liver and right panel shows that on the kidney 
against CCl4 induced SOD levels. Cont: SOD level in normal 
mice, CCl4: SOD level in only CCl4 treated mice, TA+CCl4: 
SOD level in which extract was given at a dose 50 mg/kg 
body weight prior to CCl4 administration, VitE+CCl4: SOD 
level in which vitamin E was given at a dose of 200 mg/kg 
body weight prior to CCl4 administration. Each column rep-
resents mean ± SD, n = 6; (P* < 0.01, P** < 0.001).
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Effect of the aqueous TA extract on lipid peroxidation
TBARS concentrations (expressed as MDA) in the liver and
kidney homogenates of all experimental mice are shown
in figure 9. In liver tissue homogenates of CCl4 treated
group elevation of MDA level was observed compared to
the normal control. Pretreatment of aqueous extract for 7
days followed by CCl4 treatment for 2 days decreased the
level of MDA compared to CCl4 treated group. Likewise,
in the kidney tissue homogenates the MDA level in CCl4
treated group was also higher than the normal group.
Treatment of the aqueous extract prior to the CCl4 admin-
istration decreased the enhanced MDA level significantly.
Similar results were obtained with vitamin E.
Discussion
Present study was conducted to evaluate the protective
effect of the aqueous extract of TA against CCl4 induced
hepatic and renal disorders in mice. Results suggest that
the extract possesses protective action against both hepatic
and renal dysfunctions induced by the potent toxin, CCl4.
Data showed that the extract responds in both dose- and
time-dependent manner. Maximum protective activity of
the extract was obtained when administered once daily at
a dose of 50 mg/kg body weight for 7 days before toxin
administration as revealed from the figures 2 and 3. This
dose and time have been followed for the subsequent
studies.
A number of chemicals including various environmental
toxicants and clinically useful drugs can cause severe cel-
Effect of aqueous TA extract on the GSH levels in CCl4  induced hepatic and renal damages in mice Figure 8
Effect of aqueous TA extract on the GSH levels in CCl4 
induced hepatic and renal damages in mice. Aqueous extract 
of TA was administered orally 7 days prior to CCl4 treat-
ment (1 ml/kg body weight). For experimental detail, see the 
materials and methods. Left panel shows the effects of the 
extract on liver and right panel shows that on the kidney 
against CCl4 induced GSH levels. Cont: GSH level in normal 
mice, CCl4: GSH level in only CCl4 treated mice, TA+CCl4: 
GSH level in which extract was given at a dose 50 mg/kg 
body weight prior to CCl4 administration, VitE+CCl4: GSH 
level in which vitamin E was given at a dose of 200 mg/kg 
body weight to CCl4 administration. Each column represents 
mean ± SD, n = 6; (P* < 0.01, P** < 0.001).
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Effect of aqueous TA extract on the GST levels in CCl4  induced hepatic and renal damages in mice Figure 7
Effect of aqueous TA extract on the GST levels in CCl4 
induced hepatic and renal damages in mice. Aqueous extract 
of TA was administered orally 7 days prior to CCl4 treat-
ment (1 ml/kg body weight). For experimental detail, see the 
materials and methods. Left panel shows the effects of the 
extract on liver and right panel shows that on the kidney 
against CCl4 induced GST levels. Cont: GST level in normal 
mice, CCl4: GST level in only CCl4 treated mice, TA+CCl4: 
GST level in which extract was given at a dose 50 mg/kg body 
weight prior to CCl4 administration, VitE+CCl4: GST level in 
which vitamin E was given at a dose of 200 mg/kg body 
weight prior to CCl4 administration. Each column represents 
mean ± SD, n = 6; (P* < 0.01, P** < 0.001).
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lular damages in different organs of our body through the
metabolic activation to highly reactive substances such as
free radicals. CCl4 is one of such extensively studied envi-
ronmental toxicant. The reactive metabolite trichlorome-
thyl radical (.CCl3) has been formed from the metabolic
conversion of CCl4 by cytochrome P-450 [50]. As O2 ten-
sion rises, a greater fraction of .CCl3 present in the system
reacts very rapidly with O2 and many orders of magnitude
more reactive free radical, CCl3OO. has been generated
from .CCl3 [51]. These free radicals initiate the peroxida-
tion of membrane poly-unsaturated fatty acids (PUFA)
[52], generates PUFA. and covalently bind to microsomal
lipids and proteins [53]. This phenomenon results in the
generation of ROS, (like the superoxide anion O2
-, H2O2
and the hydroxyl radical, .OH). Evidence suggests that var-
ious enzymatic and non-enzymatic systems have been
developed by the cell to cope up with the ROS and other
free radicals. However, when a condition of oxidative
stress establishes, the defense capacities against ROS
becomes insufficient [54]. ROS also affects the antioxi-
dant defense mechanisms, reduces the intracellular con-
centration of GSH and decreases the activity of SOD and
CAT. It has also been known to decrease the detoxification
system produced by GST [55]. Increasing evidence indi-
cates that oxidative stress causes organ injury and carcino-
genesis [56].
In the present study, it has been observed that CCl4
induced a significant elevation of the levels of serum
marker enzymes, GPT and ALP. In addition, this potent
toxicant caused significant decrease in SOD, CAT and GST
activities, depleted the GSH content and enhanced lipid
peroxidation in both liver and kidney. We also deter-
mined the levels of the markers related to renal damages.
However, under the present experimental conditions (1
ml/kg body weight for 2 days), there was no change in
either the urea nitrogen or creatinine (non protein nitro-
gen) in the serum of CCl4intoxicated animals. Besides, we
did not find any change in the creatinine level in the urine
of the experimental animals (data not shown) as well. The
exact reason for this is not clearly known. One possibility
is that, the time of CCl4 exposure to the animals was not
enough for the renal damage although oxidative stress
could be induced by that exposure. Tirkey et al [57] have
recently conducted experiments to determine the effect of
CCl4 on the renal damages in rats and obtained similar
results.
It has been reported that SOD, CAT and GST constitute a
mutually supportive team of defense against ROS [58,59].
The decreased activity of SOD in liver and kidney in CCl4
treated mice may be due to the enhanced lipid peroxida-
tion or inactivation of the antioxidative enzymes. This
would cause an increased accumulation of superoxide
radicals, which could further stimulate lipid peroxidation.
GST binds to liophilic compounds and acts as an enzyme
for GSH conjugation reactions [60]. Decrease in GSH
activity during CCl4 toxicity might be due to the decreased
availability of GSH resulted during the enhanced lipid
peroxidation. Administration of the aqueous extract of TA
prior to CCl4 intoxication could not only prevent the CCl4
induced increased levels of serum marker enzymes GPT
and ALP, but also protected the antioxidant machineries
of the liver and kidney as revealed from the enhanced lev-
els of SOD, CAT and GST activities, increased level of GSH
content and decreased level of lipid peroxidation. Besides,
the extract showed radical scavenging activity by reacting
with DPPH and this scavenging activity is comparable to
that of a potent free radical scavenger, vitamin C in cell
free system.
In the liver, CCl4 is metabolized by the cytochrome P450-
dependent monooxygenase systems followed by its con-
version to more chemically active form, trichloromethyl
radical (.CCl3) [61]. The enzymes involved in this process
are located in the endoplasmic reticulum of the liver and
their activities are dependent on many environmental fac-
tors. Some herbal extracts are known to prevent the oxida-
tive damages in different organs by altering the levels of
Effect of aqueous TA extract on TBARS formation in CCl4  induced hepatic and renal damages in mice Figure 9
Effect of aqueous TA extract on TBARS formation in CCl4 
induced hepatic and renal damages in mice. Aqueous extract 
of TAwas administered 7 days prior to CCl4 treatment (1 ml/
kg body weight). Left panel shows effects of the extract on 
liver and right panel shows that on the kidney against CCl4 
induced MDA contents. Cont: MDA content in normal mice, 
CCl4: MDA content in only CCl4 treated mice, TA+CCl4: 
MDA level in which extract was given at a dose 50 mg/kg 
body weight prior to CCl4 administration, VitE+CCl4: MDA 
level in which vitamin E was given at a dose of 200 mg/kg 
body weight prior to CCl4 administration. Each column rep-
resents mean ± SD, n = 6; (P* < 0.01, P** < 0.001).
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cytochrome P-450 through their antioxidant properties
[20]. Our results suggest that the aqueous extract of the
bark of TA possesses potent antioxidative activity and pro-
tects liver and kidney against CCl4 induced oxidative stress
probably via the alteration of cytochrome P-450.
Conclusion
Combining all, we would like to say that the aqueous
extract of TA protects liver and kidney tissues against oxi-
dative damages and could be used as an effective protector
against CCl4 induced hepatic and renal damages. Further
works are needed to fully characterize the responsible
active principle(s) present in the plant and elucidate its
possible mode of action and that is in progress.
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